Clinical Trial Update: A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A prospective Phase II study evaluating immunotherapy combined with chemotherapy for stage III unresectable non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: NSCLC | Phase 2 | Status: RECRUITING